Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate with or without intravenous vitamin C for moderate COVID-19 in Madagascar
PACTR202006899597082Phase 2Completed
- Sponsor
- Government of Madagascar
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of artesunate, ascorbic acid and isotonic saline in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Government of Madagascar. Primary endpoint: Primary efficacy assessment. Started Apr 2020; status: completed.
02
Drugs
artesunateascorbic acidisotonic saline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202006899597082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006899597082.